Drug intelligence / Profile preview

Pelvilen Dual Act

Development stage
Unknown
Lead developer
Epitech
Modality
Small Molecules
Administration
Oral, Sublingual
01

Overview

Pelvilen Dual Act is a combination product developed by Epitech Group SpA, containing micronized and ultra-micronized palmitoylethanolamide (PEA) along with the polyphenol trans-polydatin. As an ALIAmide-based formulation, it is designed to modulate the activity of mast cells and other non-neuronal immune cells, such as microglia and astrocytes, to control neuroinflammation in pelvic tissues. The addition of polydatin provides antioxidant activity to control oxidative stress associated with chronic inflammation. It is primarily indicated for the management of chronic pelvic pain associated with conditions like endometriosis, interstitial cystitis, chronic prostatitis, and irritable bowel syndrome. It is marketed as a food supplement for special medical purposes under medical supervision.

Brand names
Pelvilen Dual ActPelvilen Dual Act Compresse
Other names
PEA + Polydatin
02

Targets

PPARA (Peroxisome proliferator-activated receptor alpha)

Beyond the preview

Go deeper on Pelvilen Dual Act.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pelvilen Dual Act.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call